These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6262480)
21. Probing the importance of spacial and conformational domains in captopril analogs for angiotensin converting enzyme activity. Hanessian S; Reinhold U; Saulnier M; Claridge S Bioorg Med Chem Lett; 1998 Aug; 8(16):2123-8. PubMed ID: 9873498 [TBL] [Abstract][Full Text] [Related]
22. Hypoxia preadaptation prevents oxygen-induced depression of lung angiotensin-converting enzyme activity. Jackson RM; Pisarello JB Am Rev Respir Dis; 1984 Sep; 130(3):424-8. PubMed ID: 6089627 [TBL] [Abstract][Full Text] [Related]
23. Induction of angiotensin I-converting enzyme in rat lung with captopril: the effect of adrenalectomy. Fyhrquist F; Grönhagen-Riska C; Forslund T; Tikkanen I Am J Cardiol; 1982 Apr; 49(6):1508-10. PubMed ID: 6280480 [TBL] [Abstract][Full Text] [Related]
24. Increase of serum and membrane-bound angiotensin-converting enzyme by captopril (SQ 14225) treatment. Grönhagen-Riska C; Forslund T; Hortling L; Fyhrquist F Acta Med Scand Suppl; 1983; 677():101-4. PubMed ID: 6322528 [No Abstract] [Full Text] [Related]
25. Development of specific inhibitors of angiotensin I converting enzyme (kininase II). Cushman DW; Cheung HS; Sabo EF; Rubin B; Ondetti MA Fed Proc; 1979 Dec; 38(13):2778-82. PubMed ID: 228989 [No Abstract] [Full Text] [Related]
26. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca. Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904 [TBL] [Abstract][Full Text] [Related]
27. Tissue angiotensin-converting enzyme blockade by MC-838 (altiopril calcium) infused intravenously to miniature pigs: comparison with captopril. Sakai K; Shiraki Y; Akima M; Imagawa J; Hinohara Y; Koga T; Ichihara T; Tohira Y Arch Int Pharmacodyn Ther; 1988; 294():228-40. PubMed ID: 2852930 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of endothelial-bound angiotensin converting enzyme, in vivo. Catravas JD; Ryan JW; Chung AY; Quinn NE; Anthony BL Br J Pharmacol; 1990 Sep; 101(1):121-7. PubMed ID: 2282454 [TBL] [Abstract][Full Text] [Related]
29. Lung angiotensin-converting enzyme kinetics from indicator-dilution and constant-infusion methods. Linehan JH; Bongard RD; Roerig DL; Bronikowski TA; Dawson CA Am J Physiol; 1990 Feb; 258(2 Pt 2):H436-44. PubMed ID: 2155544 [TBL] [Abstract][Full Text] [Related]
30. Kinetics of pulmonary angiotensin-converting enzyme activity in conscious developing lambs. Pitt BR; Lister G J Appl Physiol Respir Environ Exerc Physiol; 1984 Oct; 57(4):1158-66. PubMed ID: 6094403 [TBL] [Abstract][Full Text] [Related]
32. [Biochemical and physiological characteristics of the kininase and angiotensin-converting function of the lungs]. Gomazkov OA; Trapeznikova SS Usp Sovrem Biol; 1978; 86(2):259-68. PubMed ID: 214969 [No Abstract] [Full Text] [Related]
34. Uptake of N-[1 (S)-carboxy-(4-OH-3-125I-phenyl)ethyl]-L-Ala-L-Pro, an inhibitor of angiotensin-converting enzyme by rabbit lungs in situ. Turrin M; Pitt BR; Ryan JW; Chung AY; Clark MB; Gillis CN J Pharmacol Exp Ther; 1986 Jul; 238(1):14-8. PubMed ID: 3014113 [TBL] [Abstract][Full Text] [Related]
35. Effects of captopril on bradykinin-induced, prostaglandin-mediated bronchoconstriction in the guinea pig. Greenberg R; Osman GH; O'Keefe EH; Antonaccio MJ Adv Prostaglandin Thromboxane Res; 1980; 7():961-4. PubMed ID: 6989210 [No Abstract] [Full Text] [Related]
36. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction. van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077 [TBL] [Abstract][Full Text] [Related]
37. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril. Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of the angiotensin I converting enzyme of the lung by a peptide fragment of bradykinin. Oshima G; Erdös EG Experientia; 1974 Jul; 30(7):733-4. PubMed ID: 4367995 [No Abstract] [Full Text] [Related]
39. Effect of a fibrin-derived vasoactive peptide on pulmonary angiotensin converting enzyme activity and on pressure responses to bradykinin. Moalli R; Saldeen K; Saldeen T J Pharmacol Exp Ther; 1987 Dec; 243(3):897-900. PubMed ID: 3694536 [TBL] [Abstract][Full Text] [Related]
40. Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production. Azizi M; Junot C; Ezan E; Hallouin MC; Guyene T; Ménard J J Mol Med (Berl); 2002 Aug; 80(8):492-8. PubMed ID: 12185449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]